Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neratinib vs Trastuzumab + Paclitaxel in HER2+ Breast Cancer
NCT00915018Phase 2Completed
- Sponsor
- Puma Biotechnology, Inc.
- Start
- Aug 2009
- Primary completion
- Aug 2013
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 35
01
Overview
A Phase 2 trial of neratinib in breast cancer, sponsored by Puma Biotechnology, Inc.. Started Aug 2009; status: completed.
02
Drugs
neratinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00915018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915018.